// App-Quantinova.ai

e14505 : CNS outcomes in EGFR/ALK wild-type NSCLC patients with brain metastases treated with immune checkpoint inhibitors (ICI).

Researchers

Presenter

  • David Benjamin Shultz

Principal Investigators

  • Sally CM Lau

  • Christopher Poletes

  • Lisa W Le

  • Kate MacKay

  • Frances A. Shepherd

  • Penelope Ann Bradbury

  • Natasha B. Leighl

  • Geoffrey Liu

  • Adrian G. Sacher

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Universtiy Health Network, Toronto, ON, Canada

  • Cancer Clinical Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Anaplastic lymphoma Kinase

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved